ULCERATIVE COLITIS AND CORTIMENT^® PATIENT LEAFLET

Support your patients prescribed CORTIMENT^® to treat their UC by simply emailing a link to this leaflet which contains FAQs such as:

• Why have I been prescribed CORTIMENT^®?
• What is the difference between systemic steroids and CORTIMENT^®?
• How and when to take CORTIMENT^®

MICROSCOPIC COLITIS AND CORTIMENT^® PATIENT LEAFLET

Support your patients prescribed CORTIMENT^® to treat their MC by simply emailing a link to this leaflet which contains FAQs such as:

• What is Microscopic Colitis?
• Why have I been prescribed CORTIMENT^®?
• How and when to take CORTIMENT^®

CORTIMENT^® Product Monograph

The CORTIMENT Product Monograph contains a comprehensive overview of CORTIMENT’s use within its licensed therapeutic areas. You will find information on Ulcerative and Microscopic Colitis, the rationale for CORTIMENT’s development, its mechanism of action, and clinical data from randomised controlled trials and real world evidence.

CORTIMENT^® PATIENT VIDEO

‘Living with Ulcerative Colitis; A CORTIMENT^® Patient’s Perspective’

Hear directly from a patient about her experience of living with UC and the importance of her IBD Nurse Specialist.

During this video you will hear about her personal experiences, from the challenges of gaining a diagnosis to dealing with the side effects caused by her medications and eventually coming to terms with her diagnosis.

CORE PRACTICE STUDY

The CORE Practice is a Real World Evidence study published by Danese S, et al. J Crohns Colitis. 2019;13(supplement 1):296-297

This looks at results from a prospective, multi-centre, observational cohort study assessing the effectiveness of CORTIMENT^® for mild to moderate active UC.

iSTART Paper

iSTART (iSupport Therapy-Access to Rapid Treatment) is a Ferring Pharmaceuticals initiative consisting of a global expert panel to improve patient-centred management for mild to moderate UC.

GUIDANCE ON PRESCRIBING CORTIMENT^® BY BRAND

This leaflet provides useful information including:

• The differences between MMX and non-MMX budesonides
• Writing the correct name on the script to ensure Cortiment^® is dispensed

INTERNATIONAL REAL WORLD EVIDENCE

This leaflet provides a summary of key Real World Evidence studies using CORTIMENT^®for the treatment of flaring Ulcerative Colitis:

• International CORE Practice study Danese et al. 2019
• National Audit Kearns et al. 2020

CORTIMENT^® – TREATMENT FOR MICROSCOPIC COLITIS

This leaflet provides an overview of Microscopic Colitis and how CORTIMENT^® can be used to treat patients with Active Microscopic Colitis